FDA Announces Public Hearing on Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox

U.S. Food and Drug Administration sent this bulletin at 01/12/2022 10:00 AM EST

If your email program has trouble displaying this email, view as a webpage.
US Food and Drug Administration

FDA Announces Public Hearing on Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox

The Food and Drug Administration will hold a public hearing on Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox, a carcinogenic new animal drug used in swine feed. The public hearing will be held virtually on March 10, 2022, via Zoom from 1:00 to 5:00 p.m. ET.

Read More Button


You are subscribed to updates from FDA's Center for Veterinary Medicine.